The use of modified Ponticelli regimens for primary membranous nephropathy

The use of modified Ponticelli regimens for primary membranous nephropathy

Bibliographic Details
Main Author:	Macaulay Amechi Chukwukadibia Onuigbo
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2019-10-01
Series:	Journal of Nephropathology
Subjects:	immunosuppression modified ponticelli primary membranous nephropathy
Online Access:	https://nephropathol.com/PDF/jnp-8-34.pdf

Similar Items

Efficacy and safety of a modified- ‘modified Ponticelli’ regimen for treatment of primary membranous nephropathy
by: Indu Ramachandra Rao, et al.
Published: (2019-07-01)

New Isolation of Ponticelli III Virus (<i>Bunyavirales</i>: <i>Phenuiviridae</i>) in Emilia-Romagna Region, Italy
by: Mohamed Daoudi, et al.
Published: (2023-02-01)

The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy ——protocol of a multicenter, randomized control trial (SQ-AUTUMN)
by: Chuang Li, et al.
Published: (2023-04-01)

Clinical analysis of rituximab for adult refractory primary membranous nephropathy
by: FENG Linhong, et al.
Published: (2023-03-01)

Cytomegalovirus glomerulopathy in renal allografts
by: Macaulay Amechi Chukwukadibia Onuigbo
Published: (2020-01-01)

Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy
by: Hui-Lin Xing, et al.
Published: (2024-02-01)

Computer-aided diagnosis of primary membranous nephropathy using expert system
by: Jie Gao, et al.
Published: (2023-02-01)

Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
by: Roxana Jurubiță, et al.
Published: (2021-06-01)

Clinical covariates influencing clinical outcomes in primary membranous nephropathy
by: Lukas Westermann, et al.
Published: (2023-08-01)

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
by: Wanyi Xu, et al.
Published: (2023-04-01)

How to Choose the Right Treatment for Membranous Nephropathy
by: Luigi Peritore, et al.
Published: (2023-11-01)

The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy
by: Suyan Duan, et al.
Published: (2023-12-01)

The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study
by: Liu Y, et al.
Published: (2023-05-01)

Primary Membranous Nephropathy - what do we know today?
by: Marcin Wais, et al.
Published: (2023-05-01)

Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
by: Bao Neng, et al.
Published: (2023-01-01)

B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management
by: Benjamin Y. F. So, et al.
Published: (2021-12-01)

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
by: Jinxiu Liang, et al.
Published: (2023-12-01)

A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy
by: Min Li, et al.
Published: (2023-12-01)

Prognosis and incidence of infections in chronic kidney disease patients with membranous nephropathy enrolled in a large Japanese clinical claims database
by: Takuro Matsuzaki, et al.
Published: (2023-05-01)

Prediction Models of Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis
by: Chanyu Geng, et al.
Published: (2023-01-01)

Renal Allograft Biopsies with Polyomavirus BK Nephropathy: Turin Transplant Center, 2015–19
by: Elisa Zanotto, et al.
Published: (2020-09-01)

A nomogram prediction model for treatment failure in primary membranous nephropathy
by: Chanyu Geng, et al.
Published: (2023-12-01)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
by: Olga Lesya Kukuy, et al.
Published: (2023-05-01)

Association of circulating proprotein convertase subtilisin/kexin type 9 concentration with coagulation abnormalities in patients with primary membranous nephropathy
by: Huizi Zhu, et al.
Published: (2023-12-01)

The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy
by: Deniz Filinte, et al.
Published: (2020-06-01)

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China
by: Li Zeng, et al.
Published: (2024-01-01)

Complement activation products in the circulation and urine of primary membranous nephropathy
by: Mu-fan Zhang, et al.
Published: (2019-08-01)

Mechanisms of Primary Membranous Nephropathy
by: Yan Gu, et al.
Published: (2021-03-01)

Role of light and immunofluorescence microscopy to differentiate primary and secondary membranous nephropathy
by: Keya Basu, et al.
Published: (2022-01-01)

The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin
by: Macaulay Amechi Onuigbo, et al.
Published: (2018-05-01)

Membranous nephropathy with light chain restriction
by: Catarina Isabel Ribeiro, et al.
Published: (2021-01-01)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
by: Jia-Wei He, et al.
Published: (2022-03-01)

Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024-02-01)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024-03-01)

Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
by: Francesca Zanoni, et al.
Published: (2023-08-01)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
by: Jia-Wei He, et al.
Published: (2023-06-01)

Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
by: Yuanyuan Zhang, et al.
Published: (2024-03-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

Significance of thyroid dysfunction in the patients with primary membranous nephropathy
by: Qiu-hua Gu, et al.
Published: (2022-12-01)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
by: Hongyun Wang, et al.
Published: (2023-08-01)